M. Harler

842 total citations
13 papers, 610 citations indexed

About

M. Harler is a scholar working on Transplantation, Infectious Diseases and Epidemiology. According to data from OpenAlex, M. Harler has authored 13 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Transplantation, 5 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in M. Harler's work include Renal Transplantation Outcomes and Treatments (9 papers), HIV/AIDS drug development and treatment (5 papers) and CAR-T cell therapy research (2 papers). M. Harler is often cited by papers focused on Renal Transplantation Outcomes and Treatments (9 papers), HIV/AIDS drug development and treatment (5 papers) and CAR-T cell therapy research (2 papers). M. Harler collaborates with scholars based in United States, France and Spain. M. Harler's co-authors include P. Massari, Valter Duro Garcı́a, Philippe Lang, Mamta Agarwal, Lionel Rostaing, J. Xing, Christian P. Larsen, Barbara A. Bresnahan, Eduardo Mancilla Urrea and B Charpentier and has published in prestigious journals such as Frontiers in Immunology, Annals of the Rheumatic Diseases and Transplantation.

In The Last Decade

M. Harler

13 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Harler United States	5	454	253	171	140	87	13	610
P. Darji India	2	545 1.2×	262 1.0×	165 1.0×	221 1.6×	90 1.0×	4	704
J.M. Boria Grinyo United States	2	509 1.1×	239 0.9×	142 0.8×	164 1.2×	130 1.5×	2	649
C. Schönemann Germany	11	471 1.0×	280 1.1×	159 0.9×	205 1.5×	58 0.7×	31	658
Lucile Amrouche France	13	374 0.8×	263 1.0×	148 0.9×	101 0.7×	58 0.7×	32	674
J. Xing United States	7	542 1.2×	234 0.9×	189 1.1×	188 1.3×	111 1.3×	12	726
A. Zeevi United States	16	355 0.8×	334 1.3×	154 0.9×	168 1.2×	51 0.6×	34	705
M.L. Farrell United States	8	280 0.6×	205 0.8×	134 0.8×	138 1.0×	116 1.3×	11	546
Maria Ajaimy United States	13	363 0.8×	181 0.7×	86 0.5×	86 0.6×	88 1.0×	33	553
Graeme Russ Australia	13	359 0.8×	179 0.7×	96 0.6×	41 0.3×	111 1.3×	30	491
Rafael Reyes‐Acevedo Mexico	8	309 0.7×	146 0.6×	123 0.7×	102 0.7×	78 0.9×	19	444

Countries citing papers authored by M. Harler

Since Specialization

Citations

This map shows the geographic impact of M. Harler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Harler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Harler more than expected).

Fields of papers citing papers by M. Harler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Harler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Harler. The network helps show where M. Harler may publish in the future.

Co-authorship network of co-authors of M. Harler

This figure shows the co-authorship network connecting the top 25 collaborators of M. Harler. A scholar is included among the top collaborators of M. Harler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Harler. M. Harler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Robinson, William H., David Fiorentino, Leland W.K. Chung, et al.. (2024). Cutting-edge approaches to B-cell depletion in autoimmune diseases. Frontiers in Immunology. 15. 1454747–1454747. 13 indexed citations

Domingo-Gonzalez, Racquel, Miho Oyasu, Kimberly W. Hart, et al.. (2024). POS1062 THERAPEUTIC POTENTIAL OF IMVOTAMAB, A CD20-TARGETED BISPECIFIC IGM T CELL ENGAGER, FOR THE TREATMENT OF REFRACTORY AUTOIMMUNE DISEASE PATIENTS. Annals of the Rheumatic Diseases. 83. 935–935. 2 indexed citations

Blancho, Gilles, Klemens Budde, Pierre Merville, et al.. (2014). Outcomes at 3 Years in EBV+ European Subpopulations From BENEFIT and BENEFIT-EXT.. Transplantation. 98. 455–455. 1 indexed citations

Grinyó, Josep M., Brad A. Marder, M. Harler, et al.. (2014). Outcomes at 4 Years in a Randomized Trial Evaluating Belatacept-Based Regimens With Simultaneous CNI and Steroid-Avoidance in Kidney Transplant.. Transplantation. 98. 116–117. 1 indexed citations

Bray, Robert A., Howard M. Gebel, Patricia Brannon, et al.. (2014). Evaluation of Donor-Specific Antibodies Through 5 Years With Belatacept in BENEFIT and BENEFIT-EXT.. Transplantation. 98. 117–117. 4 indexed citations

Woodle, E. Steve, Brad A. Marder, M. Harler, et al.. (2014). Renal Function at 4 Years in a Phase 2 Randomized Trial Evaluating Belatacept-Based Regimens With Simultaneous Calcineurin Inhibitor and Corticosteroid Avoidance in Kidney Transplant Recipients.. Transplantation. 98. 114–115. 1 indexed citations

Klintmalm, Göran B., Sandy Feng, John R. Lake, et al.. (2014). Belatacept-Based Immunosuppression in De Novo Liver Transplant Recipients: 1-Year Experience From a Phase II Randomized Study. American Journal of Transplantation. 14(8). 1817–1827. 101 indexed citations

Pestana, José Osmar Medina, J.M. Grinyó, Yves Vanrenterghem, et al.. (2012). Three-Year Outcomes From BENEFIT-EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys. American Journal of Transplantation. 12(3). 630–639. 184 indexed citations

Vincenti, F., Bruno Charpentier, Lionel Rostaing, et al.. (2012). Long-Term Extension of the Belatacept BENEFIT Study: Results at Month 48. Transplantation. 94(10S). 101–101. 1 indexed citations

10.

Grinyó, J. M., Sander Florman, José Osmar Medina Pestana, et al.. (2012). Long-Term Extension of the Belatacept BENEFIT-EXT Study: Results at Month 48. Transplantation. 94(10S). 974–974. 1 indexed citations

11.

Vincenti, Flavio, Christian P. Larsen, Josefina Alberú, et al.. (2011). Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients. American Journal of Transplantation. 12(1). 210–217. 238 indexed citations

12.

Dürrbach, Antoine, Franco Citterio, Elias David‐Neto, et al.. (2011). RENAL FUNCTION IN PATIENTS TREATED WITH BELATACEPT-OR CYCLOSPORINE-BASED REGIMENS AT YEAR 3 IN THE BENEFIT AND BENEFIT-EXT STUDIES. Veterinary World. 24(10). 249–250. 3 indexed citations

13.

Demopoulos, Laura A., Martin S. Polinsky, Daniel Mines, et al.. (2008). Reduced Risk of Cytomegalovirus Infection in Solid Organ Transplant Recipients Treated With Sirolimus: A Pooled Analysis of Clinical Trials. Transplantation Proceedings. 40(5). 1407–1410. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact